Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverPHG
HealthcareNYQUSD

Koninklijke Philips N.V.

$0012345678900123456789.0012345678900123456789-2.5%
52w low $23.70$33.44 52w high
Market data · updated 12h ago
Market data
Market cap
$24.21B
52w range
$23.70 - $33.44
Beta
0.91
Sector
Healthcare
Data quality
100/100
Valuation
P/E ratio
19.1x
fair value estimate
$50.05
Margin of safety
+110.2%
Forward P/E
13.0x
PEG ratio
0.76
Dividend yield
4.09%
Quality & efficiency
Moat score
48/100
Return on equity
10.2%
Profit margin
6.3%
Debt / equity
0.65
Growth & analysts
Revenue growth
+0.5%
Analyst target
$32.21
Target upside
+35.3%
Analysts
5
Run the 10-point checklist before you buy How these numbers are made

About Koninklijke Philips N.V.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Valuation

ValueGrowthProfitHealthIncome57QUALITY
Overall Rating
76
High quality
High quality

Derived from filed metrics · High confidence (100% of the inputs available)

Moat Score48
Fair value estimate
$50.05+110.2% upside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$24.21B
P/E Ratio
19.1
Dividend Yield
4.09%
Revenue Growth
+0.5%
Profit Margin
6.3%
ROE
10.2%
Debt / Equity
0.65
Beta
0.91
Dividend Aristocrats

Statistics

Similar Stocks · Healthcare

Latest News · PHG